02251 AIRDOC-B
- 15.540
- +0.160+1.04%
AIRDOC-B News
Baili Tianheng and Shenzhou Cell turned losses into profits! Many biomedical companies on the Science and Technology Innovation Board ushered in a “good start” in Q1
In the first quarter of 2024, many parts of the country successively issued relevant policies to support the high-quality development of the biomedical industry or innovative pharmaceutical devices to continuously optimize the biomedical innovation environment.
鷹瞳科技-B：2023年年度報告
Beijing Airdoc Arm Setting Up 500 Million Yuan Fund
Beijing Airdoc Technology (HKG:2251) arm Shanghai Zhongyou Intelligent Technology will partner with Wenzhou Lufeng Asset Management and Minsheng Equity Investment Fund Management to float a 500 millio
Eagle Hitomi Technology-B (02251.HK) signs partnership agreement with Wenzhou Lufeng and Minsheng Equity Fund
Gelonghui, April 16, 丨 Eagle Eye Technology-B (02251.HK) announced that on April 16, 2024, Shanghai Zhongyou (a wholly-owned subsidiary of the company) signed a partnership agreement with Wenzhou Lufeng and Minsheng Equity Fund to establish a partnership. The total capital pledged by all partners under the partnership agreement is RMB 500 million, of which Shanghai Zhongyou promised to invest RMB 250 million. Partnerships shall make equity or other forms of investment permitted by applicable law, mainly in the fields of life sciences, healthcare services, smart medicine, and artificial intelligence. Since the company focuses on using artificial intelligence technology, it is slow
Eagle Hitomi Technology-B (02251.HK) received 167,400 H shares from Tomasz Jakub Mialkos to an increase of 167,400 shares worth approximately HK$2,764,500
On April 15, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 15, Tomasz Jakub Mialkos increased its holdings of $Eagle Hitomi Technology-B (02251.HK) $167,400 H shares at an average price of HK$16.5145 per share on April 11, worth about HK$2.7645 million. After the increase in holdings, Tomasz Jakub Mialkos's latest shareholding was 7.0191,000 shares, and the good position ratio increased from 12.82% to 13.14%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? Press the Hong Kong Federation
Eagle Hitomi Technology-B (02251.HK) received 237,000 H shares from Tomasz Jakub Mialkos, worth approximately HK$4.143 million
On April 11, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 11, Tomasz Jakub Mialkos increased its holdings of $Eagle Hitomi Technology-B (02251.HK) $237,000 with an average price of HK$17.4812 per share on April 8, worth about HK$4.143 million. After the increase in holdings, Tomasz Jakub Mialkos's latest shareholding was 6.601 million shares, and the good position ratio increased from 11.91% to 12.35%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange
Eagle Hitomi Technology-B (02251.HK) received an increase of 92,000 H shares by Tomasz Jakub Mialkos, worth approximately HK$1,587,200
On April 2, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 2, Tomasz Jakub Mialkos increased its holdings of $Eagle Hitomi Technology-B (02251.HK) $92,000 H shares at an average price of HK$17.2522 per share on March 27, worth about HK$1,587,200. After the increase in holdings, Tomasz Jakub Mialkos's latest shareholding was 5.921 million shares, and the good position ratio rose from 10.91% to 11.08%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange
Eagle Eye Technology-B (2251.HK) Immediate Review: Rapid Revenue Growth, Broad Prospects for Medical AI
Incident: The company announced its 2023 results. Operating revenue was RMB 204 million, up 79.5% year on year, achieving gross profit of 125 million yuan, up 124% year on year, and net loss narrowed to 146 million yuan, down 2 percent year on year
At a Glance | Airdoc (02251.HK) 2023 Annual Results
On March 27, 2023, Airdoc (2251.HK) announced its 2023 annual results.The company's revenue increased by 79.5% year-on-year, and gross profit increased by 124% year-on-year, achieving both revenue and
Eagle Hitomi Technology (2251.HK): Commercialization accelerates, AI medical imaging leader will reach an inflection point in performance
Technology is changing the world, and the application of AI technology may accelerate the arrival of the grand vision of “changing the world.” Recently, the “Godfather of AI” Hwang In-hoon declared in various public forums that “AI+ medical systems/biology” is the next shocking revolution to be ushered in in the field of technology. “The future of life science will be as highly engineered as traditional industries. When data science, artificial intelligence, and automation are combined, biology will improve exponentially, making it the next golden track.” This statement not only set off a boom in artificial intelligence and AI medicine in the capital market, but also made investors set their sights on those already looking ahead in this field
Eagle Eye Technology-B (02251.HK): 2023 results are in line with market expectations, further commercialization implemented
The 2023 results are in line with market expectations. The company announced the 2023 results: revenue of 204 million yuan, an increase of 79.5% over the previous year; net loss to mother 133 million yuan (net loss to mother of 180 million yuan in 2022).
Understand the highlights of the 2023 annual results of Eagle Hitomi Technology (2251.HK) in one picture
On March 27, Eagle Eye Technology (2251.HK, Airdoc) announced the 2023 annual results report. Let me take you to understand the specific results in a picture.
Eagle Hitomi Technology Announces 2023 Annual Results: Revenue Increased by 79.5%, Gross Profit Increased, and Retinal AI Tests Reached 6.83 Million
On March 27, medical AI company Eagle Hitomi Technology (2251.HK, Airdoc) announced its 2023 annual results report. During the reporting period, the company's revenue increased to 203.9 million yuan, an increase of 79.5% over the previous year. The company continued to improve its profitability, achieving gross profit of 125 million yuan, an increase of 124% over the previous year; gross margin increased by 12.2 percentage points to 61.3%, achieving both gross profit and gross margin growth. In 2023, a total of 6.83 million cases were served through SaMD and health risk assessment solutions, 31,459 major positive cases were identified, and active use
Eagle Hitomi Technology-B (02251) announces 2023 annual results with revenue of 204 million yuan, up 79.46% year-on-year
Eagle Hitomi Technology-B (02251) announced results for the year ended December 31, 2023. The group achieved...
AIRDOC-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Eagle Hitomi Technology-B (02251.HK) received 186,800 H shares from Tomasz Jakub Mialkos to an increase of about HK$2.962,800
On March 25, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 25, Tomasz Jakub Mialkos increased its holdings of $Eagle Hitomi Technology-B (02251.HK) by $186,800 H shares at an average price of HK$15.8608 per share on March 20, worth about HK$2.962,800. After the increase in holdings, Tomasz Jakub Mialkos's latest shareholding was 5.3522 million shares, and the good position ratio rose from 9.67% to 10.01%. Image source: Stock Exchange shares revealed why the actors increased their holdings but held
AIRDOC-B: DATE OF BOARD MEETING
Eagle Hitomi Technology-B (02251.HK) received 327,200 H shares from Tomasz Jakub Mialkos to an increase of about HK$4,5792 million
On March 11, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 11, Tomasz Jakub Mialkos increased its holdings of $Eagle Hitomi Technology-B (02251.HK) $327,200 H shares at an average price of HK$13.995 per share on March 8, worth about HK$4.5792 million. After the increase in holdings, Tomasz Jakub Mialkos's latest shareholding was 4.864 million shares, and the good position ratio increased from 8.49% to 9.10%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange,
Changes in Hong Kong stocks | Eagle Hitomi Tech-B (02251) rose more than 6%, and Tomasz Jakub Mialkos recently increased its holdings by 55,000 shares
Eagle Hitomi Technology-B (02251) rose more than 6%. As of press release, it was up 6.12% to HK$13.52, with a turnover of HK$1,9541 million.
Eagle Hitomi Technology-B (02251.HK) received 55,000 additional H shares by Tomasz Jakub Mialkos, worth approximately HK$759,600
On March 1, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 1, Tomasz Jakub Mialkos increased its H share holdings of $Eagle Hitomi Technology-B (02251.HK) by $55,000 at an average price of HK$13.8106 per share on February 29, worth about HK$759,600. After the increase in holdings, Tomasz Jakub Mialkos's latest shareholding was 4.278,900 shares, and the good position ratio increased from 7.90% to 8.01%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, large stocks
Analysis
Price Target
No Data
